A new study by MIT researchers provides evidence that glaucoma may be caused by an autoimmune disease, according to a HealthDay News piece published by UPI. “Further research will try to determine whether other parts of the immune system play a role in glaucoma, and whether autoimmunity is a factor in degenerative brain diseases.”
MIT researchers have discovered that probiotics can prevent cholera and treat early stage cases of the disease, reports Laney Ruckstuhl for The Boston Globe. The findings, led by Prof. James Collins, “could have implications for other diseases as well because scientists were previously unaware that bacterial infections could be vulnerable to naturally occurring probiotics,” notes Ruckstuhl.
Yahoo! reporter Elise Solé highlights how Alejandra Falla successfully completed her PhD studies at MIT while pregnant with her daughter, Clara. Clara sported a miniature MIT regalia to Commencement. “It started as a joke but we decided that Clara had earned her Ph.D. in the womb,” says Falla. “She deserved to graduate with me.”
Researchers from a number of universities, including MIT, have developed a new refillable, implantable device that can deliver drugs to the heart tissue to help treat a heart attack, reports Xinhua. "After a heart attack we could use this device to deliver therapy to prevent a patient from getting heart failure," explains Prof. Ellen Roche.
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a wireless ingestible sensor that could one day be used to diagnose and treat disease. “The most exciting thing is that we can wirelessly control tiny implants even though they have no batteries at all,” says Prof. Fadel Adib.
Researchers at MIT have developed a device “that can receive power and communicate wirelessly from inside the body,” which could eventually be used for drug delivery, to treat disease or to monitor overall health, reports Allen Cone for UPI. "Having the capacity to communicate with these systems without the need for a battery would be a significant advance," said research affiliate Gio Traverso.
A new study led by Prof. Li-Huei Tsai reveals more information about the possible link between Alzheimer’s disease and the gene variant APOE4, writes Martin Finucane for The Boston Globe. The researchers discovered that by editing the gene into the more common APOE3 variant, “they could eliminate the signs of Alzheimer’s in brain cells,” said Finucane.
Using specially engineered E. coli bacteria and electronics that fit into an ingestible pill, MIT researchers have created a device that can detect internal diseases and send wireless alerts, reports Karen Kaplan for The Los Angeles Times. The device could eliminate the need for colonoscopies, which alter “the physiology inside the intestines, potentially masking signs of disease,” explains Kaplan.
USA Today reporter Sean Rossman writes about how MIT researchers have created an ingestible sensor that can monitor the digestive tract and send information to a smartphone or tablet about a person’s health. Rossman explains that the device, “can detect blood in the stomach, something that would otherwise require an endoscopy and sedation.”
MIT researchers have developed an ingestible capsule that uses genetically engineered bacteria to detect potential health problems, reports Carla Johnson for the Associated Press. The researchers hope the capsule could eventually be used to, “find signs of ulcers, inflammatory bowel disease or even colon cancer.”
Wired reporter Megan Molteni writes that a team of MIT researchers has developed an ingestible sensor that could spot gastrointestinal issues. The sensor contains, “millions of genetically engineered glowing bacteria inside a AAA-battery-sized capsule,” Molteni explains.
Writing for the Boston Herald, Lindsay Kalter reports that MIT scientists have built an ingestible capsule that could allow doctors to diagnose gastrointestinal diseases without invasive procedures. Graduate student Mark Mimee explains that the device, “sets the stage for having a pill that can give you a big biochemical profile of the gut related to various diseases.”
Popular Mechanics reporter David Grossman writes that a new ingestible medical device developed by MIT researchers could monitor the health of the human gut. Calling the project “a true team effort,” Grossman explains that it required expertise in biological engineering techniques, electronic circuit design, materials, and gastroenterology.
Elise Takahama writes for The Boston Globe that MIT researchers have developed a new technique to create “xenoproteins,” manmade proteins that could be used to battle infectious diseases like Ebola. Unlike drugs developed with natural proteins, the xenoproteins, “are more stable, easier to administer, and manufactured more quickly,” Takahama explains.
Assistant Prof. Lydia Bourouiba is highlighted in a documentary series that aims to inspire future generations of women in STEM. Producer Emily Driscoll writes in Scientific American that Bourouiba’s work studying droplets from sneezes and toilet flushes “could mean new designs for hospitals and our understanding of disease transmission.”